Discontinue Fluoxetine Immediately
If a patient develops persistent dizziness and tinnitus (ear ringing) after three weeks of fluoxetine therapy, the medication should be discontinued. These symptoms represent intolerable adverse effects that warrant stopping the drug, particularly since fluoxetine has a long half-life that provides protection against abrupt discontinuation syndrome 1.
Why These Symptoms Matter
Dizziness and tinnitus are recognized adverse effects of SSRIs, including fluoxetine 2. While dizziness is commonly listed among SSRI side effects (along with sweating, tremors, nervousness, and gastrointestinal disturbances) 3, the combination of persistent dizziness with tinnitus after three weeks suggests the patient is not tolerating the medication adequately.
Importantly, tinnitus itself can be caused by antidepressants 4, 5, creating a paradoxical situation where the medication may be worsening rather than helping the patient's overall condition. Research indicates that while SSRIs like paroxetine can sometimes help treat tinnitus in patients with comorbid depression and anxiety 6, they can also induce tinnitus as a side effect 4, 5.
How to Discontinue Fluoxetine
Due to fluoxetine's exceptionally long half-life (4-6 days for fluoxetine, 4-16 days for its active metabolite norfluoxetine), gradual tapering is less critical than with shorter-acting SSRIs 1. The drug's plasma concentrations decrease gradually after discontinuation, which naturally minimizes discontinuation syndrome risk 1, 2.
However, the FDA label still recommends gradual dose reduction when possible rather than abrupt cessation 2. A reasonable approach:
- Reduce to half the current dose for 1-2 weeks, then stop
- Monitor for discontinuation symptoms (though less likely with fluoxetine than paroxetine or sertraline)
- If intolerable symptoms emerge, resume the previous dose briefly before attempting a slower taper 2
What to Do Next
Switch to a different SSRI with better tolerability for this patient 7. Consider:
Sertraline or citalopram/escitalopram as preferred alternatives:
- Sertraline is well-tolerated with less effect on drug metabolism compared to other SSRIs 3
- Citalopram/escitalopram have the least effect on CYP450 enzymes and lower propensity for drug interactions 1
- Both have shorter half-lives requiring more careful monitoring during titration (1-2 week intervals) 1
Start at a low "test dose" to assess tolerability, as initial adverse effects can include anxiety or agitation 1
Increase slowly in small increments at approximately 1-2 week intervals for shorter half-life SSRIs 1
Critical Considerations
Do not continue fluoxetine hoping symptoms will resolve. Three weeks is sufficient time to determine if side effects are tolerable, and persistence of dizziness/tinnitus suggests they will not spontaneously improve
Assess for other causes of dizziness if symptoms persist after fluoxetine discontinuation, though the temporal relationship strongly suggests medication causation
Consider non-pharmacological approaches (CBT) if multiple SSRI trials fail due to side effects, as combination therapy or CBT alone may be preferable 1, 7
Avoid paroxetine as the next choice, as it has higher rates of discontinuation syndrome and has been associated with increased suicidal thinking compared to other SSRIs 1
The long half-life of fluoxetine that typically protects against withdrawal actually works in your favor here—you can discontinue relatively quickly without the severe discontinuation syndrome seen with shorter-acting agents like paroxetine 1.